1. Home
  2. STRO vs REAL Comparison

STRO vs REAL Comparison

Compare STRO & REAL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • STRO
  • REAL
  • Stock Information
  • Founded
  • STRO 2003
  • REAL 2011
  • Country
  • STRO United States
  • REAL United States
  • Employees
  • STRO N/A
  • REAL N/A
  • Industry
  • STRO Biotechnology: Biological Products (No Diagnostic Substances)
  • REAL Other Specialty Stores
  • Sector
  • STRO Health Care
  • REAL Consumer Discretionary
  • Exchange
  • STRO Nasdaq
  • REAL Nasdaq
  • Market Cap
  • STRO 292.6M
  • REAL 295.1M
  • IPO Year
  • STRO 2018
  • REAL 2019
  • Fundamental
  • Price
  • STRO $3.96
  • REAL $4.14
  • Analyst Decision
  • STRO Strong Buy
  • REAL Buy
  • Analyst Count
  • STRO 7
  • REAL 7
  • Target Price
  • STRO $12.14
  • REAL $3.89
  • AVG Volume (30 Days)
  • STRO 502.8K
  • REAL 2.4M
  • Earning Date
  • STRO 11-26-2024
  • REAL 11-04-2024
  • Dividend Yield
  • STRO N/A
  • REAL N/A
  • EPS Growth
  • STRO N/A
  • REAL N/A
  • EPS
  • STRO N/A
  • REAL N/A
  • Revenue
  • STRO $169,359,000.00
  • REAL $579,862,000.00
  • Revenue This Year
  • STRO N/A
  • REAL $10.55
  • Revenue Next Year
  • STRO N/A
  • REAL $8.32
  • P/E Ratio
  • STRO N/A
  • REAL N/A
  • Revenue Growth
  • STRO 197.83
  • REAL 2.52
  • 52 Week Low
  • STRO $2.13
  • REAL $1.52
  • 52 Week High
  • STRO $6.13
  • REAL $4.64
  • Technical
  • Relative Strength Index (RSI)
  • STRO 53.69
  • REAL 77.98
  • Support Level
  • STRO $4.01
  • REAL $3.63
  • Resistance Level
  • STRO $4.60
  • REAL $4.04
  • Average True Range (ATR)
  • STRO 0.29
  • REAL 0.25
  • MACD
  • STRO 0.06
  • REAL 0.09
  • Stochastic Oscillator
  • STRO 53.62
  • REAL 91.67

About STRO Sutro Biopharma Inc.

Sutro Biopharma Inc is a clinical-stage drug discovery, development, and manufacturing company. It is mainly engaged in the development of biopharmaceutical products. The company manufactures next-generation protein therapeutics for cancer and autoimmune disorders through its proprietary integrated cell-free protein synthesis platform, XpressCF. Products offered by the company include STRO-001 for patients with multiple myeloma and non-Hodgkin lymphoma and STRO-002 for the treatment of ovarian and endometrial cancers.

About REAL The RealReal Inc.

The RealReal is the largest pure-play luxury resale platform in the us, generating $1.7 billion in 2023 gross merchandise volume and addressing a niche (personal luxury resale) that had previously been serviced by inefficient upscale boutiques and local pawn shops. The company generates revenue via consignment and first-party sales on its online marketplace, and through a small volume of direct sales. With a hands-on approach that actively sources inventory and authenticates every item on its platform, The RealReal is able to justify much higher take rates than peers, working out to roughly 34% of net merchandise value, which excludes returns, cancellations, and first-party sales.

Share on Social Networks: